在移植后心脏重塑的性别差异
Oscar Orihuela Rodríguez1, Héctor A Carmona-Ruiz2, Ramon Espinoza Pérez3
1Clinical Department of Cardiology, UMAE Specialty Hospital, National Medical Center Siglo XXI, Mexican Intitute of Social Security, Av. Cuauhtémoc No. 330, Col. Doctores, Alcaldía Cuauhtémoc, Mexico City, CP, 06720, Mexico. orihuelao@yahoo.com.mx.
BMC nephrology
|August 7, 2025
概括
移植改善了心脏重塑,在移植后的左心室质量和左心房体积变化中观察到基于性别的显著差异.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 心脏病学 心脏病学
- 内分泌学 在内分泌学.
背景情况:
- 心血管疾病是慢性病患者死亡的主要原因.
- 慢性病与心脏重塑有关,包括左心室缩和心房扩大,这可以通过移植来逆转.
- 性激素会影响心脏结构和功能,这表明在移植后的特定性别心脏重塑中可能发挥作用.
研究的目的:
- 为了调查移植后心脏重塑变化是否在性别之间有所不同.
- 分析移植后心声学参数的基于性别的差异.
主要方法:
- 一项前性研究涉及脏移植接受者,在移植后六个月内进行监测.
- 在基线,3个月和6个月收集生化和心声回声数据.
- 使用双向ANOVA进行统计分析,以比较性别和时间之间的参数,p < 0.05被认为是显著的.
主要成果:
- 与女性相比,男性在基线时表现出更高的左心室质量指数,以及移植后的显著减少.
- 妇女在基线时左心房体积指数较大,在随访期间观察到更明显的减少.
- 在男性和女性参与者之间没有发现显著的年龄差异.
结论:
- 移植后的心脏重塑在男性和女性之间显示出不同的模式.
- 这项研究强调了移植后心脏结构变化的性别特异性反应.
相关概念视频
01:28Kidney Transplant I: Introduction
60
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
60
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
509
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
509